-
therapeutic vulnerabilities. In collaboration with the Aqeilan Lab (Hebrew University), we aim to map RS-mediated and naturally occurring DSBs in cancer cells at nucleotide resolution. Using advanced sequencing
-
with university partners at seven renowned partner sites, we have established the German Cancer Consortium (DKTK). The Institute of Translational Cancer Research and Experimental Cancer Therapy (headed by Prof. Dr
-
with university partners at seven renowned partner sites, we have established the German Cancer Consortium (DKTK). The Institute of Translational Cancer Research and Experimental Cancer Therapy (headed by Prof. Dr
-
the University of Stuttgart , offers you a unique opportunity to join one of our internationally renowned Research Groups for a doctoral study. We combine an exceptionally broad and interdisciplinary spectrum